Fig. 1From: Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacksDesigns of the COMPACT and CHANGE studies. Study medications were given twice weekly in both studies. IU international units, IV intravenous, SC subcutaneous, U unitsBack to article page